AAPL338.32-6.31 (-1.83%) ▼|ABBV288.84-6.05 (-2.05%) ▼|ABT110.16+3.96 (+3.73%) ▲|ACN260.94+2.70 (+1.05%) ▲|ADBE251.47+1.24 (+0.50%) ▲|AMAT374.53-15.56 (-3.99%) ▼|AMD466.84-37.96 (-7.52%) ▼|AMGN465.45-0.56 (-0.12%) ▼|AMT188.30+0.52 (+0.28%) ▲|AMZN245.63+5.28 (+2.20%) ▲|AVGO322.23-3.85 (-1.18%) ▼|AXP327.98+8.87 (+2.78%) ▲|BA175.40+3.85 (+2.24%) ▲|BAC49.57-0.44 (-0.88%) ▼|BKNG153.75+5.62 (+3.79%) ▲|BLK1,167.15+19.61 (+1.71%) ▲|BMY63.02+0.54 (+0.86%) ▲|BNY147.78+0.67 (+0.46%) ▲|BRK-B556.11+13.62 (+2.51%) ▲|C123.10+1.13 (+0.93%) ▲|CAT613.62-9.13 (-1.47%) ▼|CL97.43+2.14 (+2.25%) ▲|CMCSA23.87+0.65 (+2.80%) ▲|COF210.77+5.92 (+2.89%) ▲|COP146.84-7.19 (-4.67%) ▼|COST1,040.55+28.27 (+2.79%) ▲|CRM226.18-2.99 (-1.30%) ▼|CSCO101.61-2.90 (-2.77%) ▼|CVS88.51-1.74 (-1.93%) ▼|CVX227.77-7.75 (-3.29%) ▼|DE667.60-7.88 (-1.17%) ▼|DHR227.97-4.26 (-1.83%) ▼|DIS113.11+2.17 (+1.96%) ▲|DUK128.38+0.99 (+0.78%) ▲|EMR165.96+1.02 (+0.62%) ▲|FDX318.25+4.97 (+1.59%) ▲|GD373.46+0.87 (+0.23%) ▲|GE315.78+13.98 (+4.63%) ▲|GEV862.25+4.38 (+0.51%) ▲|GILD170.33-0.35 (-0.21%) ▼|GM89.94+2.54 (+2.91%) ▲|GOOG278.04-0.18 (-0.06%) ▼|GOOGL278.99-0.85 (-0.30%) ▼|GS898.72+4.17 (+0.47%) ▲|HD341.15+11.95 (+3.63%) ▲|HON223.77+5.44 (+2.49%) ▲|IBM252.51-5.30 (-2.06%) ▼|INTC59.97-5.79 (-8.80%) ▼|INTU352.10+11.01 (+3.23%) ▲|ISRG436.87+4.86 (+1.13%) ▲|JNJ270.56-2.64 (-0.97%) ▼|JPM340.58+3.54 (+1.05%) ▲|KO95.83+1.75 (+1.86%) ▲|LIN519.72+5.48 (+1.07%) ▲|LLY1,410.99-6.55 (-0.46%) ▼|LMT643.15+6.20 (+0.97%) ▲|LOW218.15+9.08 (+4.34%) ▲|LRCX227.56-11.55 (-4.83%) ▼|MA658.10+20.09 (+3.15%) ▲|MCD265.64+7.52 (+2.91%) ▲|MDLZ66.38+1.44 (+2.22%) ▲|MDT99.29+2.75 (+2.85%) ▲|META606.73-8.26 (-1.34%) ▼|MMM178.36+4.02 (+2.31%) ▲|MO77.17-0.86 (-1.10%) ▼|MRK148.36-1.16 (-0.78%) ▼|MS185.73+1.43 (+0.78%) ▲|MSFT507.12-14.79 (-2.83%) ▼|MU833.59-51.15 (-5.78%) ▼|NEE85.03+1.32 (+1.58%) ▲|NFLX62.34+0.26 (+0.42%) ▲|NKE39.12+0.45 (+1.16%) ▲|NOW106.01+0.89 (+0.85%) ▲|NVDA202.06-2.58 (-1.26%) ▼|ORCL119.22-11.45 (-8.76%) ▼|PEP140.42+3.08 (+2.24%) ▲|PFE30.67+0.15 (+0.49%) ▲|PG163.56+1.99 (+1.23%) ▲|PLTR178.34-5.77 (-3.13%) ▼|PM208.29-0.50 (-0.24%) ▼|QCOM162.08-2.71 (-1.64%) ▼|RTX202.79+2.99 (+1.50%) ▲|SBUX104.40+0.75 (+0.72%) ▲|SCHW88.71+0.66 (+0.75%) ▲|SO94.61+0.90 (+0.96%) ▲|SPG221.73+3.98 (+1.83%) ▲|T21.44+0.03 (+0.14%) ▲|TMO682.65-14.35 (-2.06%) ▼|TMUS160.15+3.71 (+2.37%) ▲|TSLA403.82+4.01 (+1.00%) ▲|TXN302.02+1.18 (+0.39%) ▲|UBER66.71+1.46 (+2.24%) ▲|UNH400.44-6.53 (-1.60%) ▼|UNP307.00+3.00 (+0.99%) ▲|UPS109.71+1.46 (+1.35%) ▲|USB60.49+1.04 (+1.75%) ▲|V425.51+11.92 (+2.88%) ▲|VZ45.05+0.32 (+0.72%) ▲|WFC85.89+2.49 (+2.99%) ▲|WMT127.69+4.18 (+3.38%) ▲|XOM179.67-7.58 (-4.05%) ▼|AAPL338.32-6.31 (-1.83%) ▼|ABBV288.84-6.05 (-2.05%) ▼|ABT110.16+3.96 (+3.73%) ▲|ACN260.94+2.70 (+1.05%) ▲|ADBE251.47+1.24 (+0.50%) ▲|AMAT374.53-15.56 (-3.99%) ▼|AMD466.84-37.96 (-7.52%) ▼|AMGN465.45-0.56 (-0.12%) ▼|AMT188.30+0.52 (+0.28%) ▲|AMZN245.63+5.28 (+2.20%) ▲|AVGO322.23-3.85 (-1.18%) ▼|AXP327.98+8.87 (+2.78%) ▲|BA175.40+3.85 (+2.24%) ▲|BAC49.57-0.44 (-0.88%) ▼|BKNG153.75+5.62 (+3.79%) ▲|BLK1,167.15+19.61 (+1.71%) ▲|BMY63.02+0.54 (+0.86%) ▲|BNY147.78+0.67 (+0.46%) ▲|BRK-B556.11+13.62 (+2.51%) ▲|C123.10+1.13 (+0.93%) ▲|CAT613.62-9.13 (-1.47%) ▼|CL97.43+2.14 (+2.25%) ▲|CMCSA23.87+0.65 (+2.80%) ▲|COF210.77+5.92 (+2.89%) ▲|COP146.84-7.19 (-4.67%) ▼|COST1,040.55+28.27 (+2.79%) ▲|CRM226.18-2.99 (-1.30%) ▼|CSCO101.61-2.90 (-2.77%) ▼|CVS88.51-1.74 (-1.93%) ▼|CVX227.77-7.75 (-3.29%) ▼|DE667.60-7.88 (-1.17%) ▼|DHR227.97-4.26 (-1.83%) ▼|DIS113.11+2.17 (+1.96%) ▲|DUK128.38+0.99 (+0.78%) ▲|EMR165.96+1.02 (+0.62%) ▲|FDX318.25+4.97 (+1.59%) ▲|GD373.46+0.87 (+0.23%) ▲|GE315.78+13.98 (+4.63%) ▲|GEV862.25+4.38 (+0.51%) ▲|GILD170.33-0.35 (-0.21%) ▼|GM89.94+2.54 (+2.91%) ▲|GOOG278.04-0.18 (-0.06%) ▼|GOOGL278.99-0.85 (-0.30%) ▼|GS898.72+4.17 (+0.47%) ▲|HD341.15+11.95 (+3.63%) ▲|HON223.77+5.44 (+2.49%) ▲|IBM252.51-5.30 (-2.06%) ▼|INTC59.97-5.79 (-8.80%) ▼|INTU352.10+11.01 (+3.23%) ▲|ISRG436.87+4.86 (+1.13%) ▲|JNJ270.56-2.64 (-0.97%) ▼|JPM340.58+3.54 (+1.05%) ▲|KO95.83+1.75 (+1.86%) ▲|LIN519.72+5.48 (+1.07%) ▲|LLY1,410.99-6.55 (-0.46%) ▼|LMT643.15+6.20 (+0.97%) ▲|LOW218.15+9.08 (+4.34%) ▲|LRCX227.56-11.55 (-4.83%) ▼|MA658.10+20.09 (+3.15%) ▲|MCD265.64+7.52 (+2.91%) ▲|MDLZ66.38+1.44 (+2.22%) ▲|MDT99.29+2.75 (+2.85%) ▲|META606.73-8.26 (-1.34%) ▼|MMM178.36+4.02 (+2.31%) ▲|MO77.17-0.86 (-1.10%) ▼|MRK148.36-1.16 (-0.78%) ▼|MS185.73+1.43 (+0.78%) ▲|MSFT507.12-14.79 (-2.83%) ▼|MU833.59-51.15 (-5.78%) ▼|NEE85.03+1.32 (+1.58%) ▲|NFLX62.34+0.26 (+0.42%) ▲|NKE39.12+0.45 (+1.16%) ▲|NOW106.01+0.89 (+0.85%) ▲|NVDA202.06-2.58 (-1.26%) ▼|ORCL119.22-11.45 (-8.76%) ▼|PEP140.42+3.08 (+2.24%) ▲|PFE30.67+0.15 (+0.49%) ▲|PG163.56+1.99 (+1.23%) ▲|PLTR178.34-5.77 (-3.13%) ▼|PM208.29-0.50 (-0.24%) ▼|QCOM162.08-2.71 (-1.64%) ▼|RTX202.79+2.99 (+1.50%) ▲|SBUX104.40+0.75 (+0.72%) ▲|SCHW88.71+0.66 (+0.75%) ▲|SO94.61+0.90 (+0.96%) ▲|SPG221.73+3.98 (+1.83%) ▲|T21.44+0.03 (+0.14%) ▲|TMO682.65-14.35 (-2.06%) ▼|TMUS160.15+3.71 (+2.37%) ▲|TSLA403.82+4.01 (+1.00%) ▲|TXN302.02+1.18 (+0.39%) ▲|UBER66.71+1.46 (+2.24%) ▲|UNH400.44-6.53 (-1.60%) ▼|UNP307.00+3.00 (+0.99%) ▲|UPS109.71+1.46 (+1.35%) ▲|USB60.49+1.04 (+1.75%) ▲|V425.51+11.92 (+2.88%) ▲|VZ45.05+0.32 (+0.72%) ▲|WFC85.89+2.49 (+2.99%) ▲|WMT127.69+4.18 (+3.38%) ▲|XOM179.67-7.58 (-4.05%) ▼|
15.2 C
New York
Tuesday, November 3, 2026

Tag: growth

Intas & Accord signs Agreement to acquire Prothya Biosolutions

AHMEDABAD, India, Aug. 11, 2025 /PRNewswire/ -- Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has announced the execution of an agreement to acquire...

GarageCo™ Expands Midwest Presence with Dan’s Overhead Doors Joining Its Family of Family Brands™

NORTH LIBERTY, Iowa, Aug. 11, 2025 /PRNewswire/ -- GarageCo™ is proud to announce its newest strategic partnership, Dan's Overhead Doors, a well-established garage door...

REPEAT – Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders.

Allergy Diagnostics Market Trends Analysis Report 2025-2030 | Rising Allergy Rates, Diagnostic Innovations, and Government Investments Drive Market Growth

The global allergy diagnostics market, poised to reach USD 11.63 billion by 2030, is expanding at a CAGR of 10.39% from 2025. The rise in allergies highlights the need for precise diagnostics. Major players like Thermo Fisher and Siemens are innovating to meet demand. Key growth regions include North America and Asia Pacific.
The global allergy diagnostics market, poised to reach USD 11.63 billion by 2030, is expanding at a CAGR of 10.39% from 2025. The rise in allergies highlights the need for precise diagnostics. Major players like Thermo Fisher and Siemens are innovating to meet demand. Key growth regions include North America and Asia Pacific.

Pastors David Lindell and Brandon Lindell of James River Church Launch Inspiring New Podcast, ‘Path to Purpose’

Pastors David Lindell and Brandon Lindell of James River Church have launched the Path to Purpose podcast, a monthly series featuring candid conversations with...

Dietz & Watson Unveils New Campaign Spotlighting Four Generations of Family Leadership

“The Right Way, Even If It’s the Hard Way” returns to remind consumers that high quality runs in the family
“The Right Way, Even If It’s the Hard Way” returns to remind consumers that high quality runs in the family

Vast Secures New Funding and Launches Capital Raise to Accelerate Port Augusta Green Energy Hub

SYDNEY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Vast Renewables (“Vast” or the “Company”), a leading Australian clean energy technology company, today announced that it has secured new funding from existing shareholders and launched a capital raise to support the delivery of its flagship Port Augusta Green Energy Hub and growing international project pipeline. Vast also shared several major milestones for its flagship project, Vast Solar 1 (“VS1”), including environmental approvals and grid connection progress.

VIZSLA COPPER ANNOUNCES CHANGE OF TRANSFER AGENT

VANCOUVER, BC, Aug. 11, 2025 /CNW/ - Vizsla Copper Corp. (TSXV: VCU) (OTCQB: VCUFF) (FRANKFURT: 97E0) ("Vizsla Copper" or the "Company") announces that Odyssey Trust...

VIZSLA SILVER ANNOUNCES CHANGE OF TRANSFER AGENT

NYSE: VZLA     TSX: VZLA VANCOUVER, BC, Aug. 11, 2025 /PRNewswire/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company")...

VIZSLA SILVER ANNOUNCES CHANGE OF TRANSFER AGENT

NYSE: VZLA     TSX: VZLA VANCOUVER, BC, Aug. 11, 2025 /CNW/ - Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company")...

Actelis Networks Appoints Federal Industry Veteran Mark DeVol as Chief Revenue Officer Americas

Strategic appointment strengthens Actelis' commercialization efforts and focus across Federal/Military/Local Gov. and telecommunications markets with proven sales leader bringing over 30 years of experience in defense, government, and carrier sectors
Strategic appointment strengthens Actelis' commercialization efforts and focus across Federal/Military/Local Gov. and telecommunications markets with proven sales leader bringing over 30 years of experience in defense, government, and carrier sectors

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Retrospective trial showed Overall Response Rate (ORR) improved to 86% at the end of the second 12-month period (Year 2) compared to 72% observed...

mRNA Synthesis Raw Materials Strategic Market Analysis Report 2025 | Market to Reach $2 Billion by 2030 – Rising Collaboration Between mRNA Developers and...

Market opportunities for mRNA synthesis raw materials lie in the growing demand for high-purity materials driven by mRNA therapeutics. Key drivers include advancements in mRNA technology, regulatory compliance, and supply chain resilience. Emerging applications in personalized medicine and gene editing further boost this market.
Market opportunities for mRNA synthesis raw materials lie in the growing demand for high-purity materials driven by mRNA therapeutics. Key drivers include advancements in mRNA technology, regulatory compliance, and supply chain resilience. Emerging applications in personalized medicine and gene editing further boost this market.

Lincoln Educational Services Reports Second Quarter Results and Increases Outlook for Full Year 2025

Conference Call Today at 10:00 a.m. Eastern Daylight Time
Conference Call Today at 10:00 a.m. Eastern Daylight Time

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsGrowth